Alissa Feldborg, a 3-year-old with an ultra rare genetic disease called Sandhoff, died this month after participating in a gene therapy trial.
Author: Karen Weintraub, USA TODAY
Babies without sex? Researchers are working on it. Ethicists are troubled.
Scientists are working on an approach that goes beyond IVF where babies can be made from cells other than eggs or sperm. It has ethicists worried.
Another COVID booster is now approved for older people and those at high risk
The FDA on Tuesday said people over 65 and those at high risk for coronavirus can get a second COVID booster shot. What to know about the vaccine.
In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma
An mRNA vaccine from Moderna shows promise at preventing recurrences of melanoma skin cancer, which could mark a turnaround for cancer vaccines.
Why experts worry the ‘magic’ in new weight loss medications carries a dark side
From side effects like nausea to Big Pharma’s influence, some experts caution patients to consider the downsides of drugs like Ozempic and Wegovy.
Should you ask ChatGPT for medical advice? We asked an expert — and ChatGPT.
Looking for advice about getting medical advice from a chatbot? We asked a chatbot — and an expert — what you should know.
Are sugar substitutes healthy? Research doesn’t yet offer comforting answers.
New data about the health effects of a sugar substitute leads to one more question: Are sweeteners really healthier than the real thing?
‘Public health crisis’: Autism rates rise again, with 1 in 36 children diagnosed
Many factors are likely to contribute to rising autism rates, including that diagnoses among kids of color have been catching up to white children.
Ozempic, Wegovy, Mounjaro: How these medications promote weight loss – and what you need to know
How is Wegovy different than Ozempic? What are the side effects and long-term success? Here’s a breakdown of a latest weight loss medications.
Long COVID has some weird symptoms. Face blindness may be one them.
It’s not clear how many people have developed face blindness after having COVID-19, but research suggests an infection may trigger prosopagnosia.